Tag: Medical Research
-
Divergent CRO Announces Launch of New Contract Research Organization
ATLANTA, Ga. — Divergent CRO, a leading provider of clinical services to biotech and device companies, is pleased to announce the official launch of its new Contract Research Organization (CRO). This new venture aims to revolutionize the research and development process by offering comprehensive and tailored clinical services to meet the unique needs of the…
-
Silicon Valley High School Senior Works to Improve Cystic Fibrosis Research through AI
SAN FRANCISCO, Calif. — Manasvi Pinnaka is a senior at BASIS Independent Silicon Valley in San Jose, CA. She’s also the founder and CEO of Nysha.ai, a nationally-recognized nonprofit organization committed to raising awareness for cystic fibrosis. Pinnaka’s goals are to create awareness about this disease in all races and ethnicities while empowering and educating…
-
US Kidney Research Corp Unveils Breakthrough Ultrafilter Membrane for Dialysis
ROSEVILLE, Calif. — US Kidney Research Corporation (USKRC) is delighted to announce new groundbreaking research as part of a contract with the University of Arkansas (U of A) resulting in the development of an ultrafiltration membrane with diverse filtering applications for medical and non-medical devices.
-
The Pap Corps Makes Historic $8.4 Million Donation for Cancer Research – Sylvester Comprehensive Cancer Center to Benefit from Nonprofit’s Largest Gift
DEERFIELD BEACH, Fla. — The Pap Corps Champions for Cancer Research (thepapcorps.org) recently presented a historic donation to Sylvester Comprehensive Cancer Center of $8.4 million. This gift came in two parts, $3.4 million through the volunteers’ fundraising efforts and $5 million from an anonymous donor. This is the largest single gift in the nonprofit’s 70-year…
-
Award-winning universal vaccine method calls for deeper scientific exploration – The Slammer Method
CHESAPEAKE, Va. — A new universal vaccine method developed by Eric Kikkert is outlined in an article he wrote called: “The Slammer Method: How to create effective vaccines.” It recently appeared in the “Journal of Infectious Diseases and Therapy” and is proposed to work in not just humans, but animals too. The material was presented…
-
The Pap Corps Celebrates 70 Years of Funding Research for All Types of Cancer
DEERFIELD BEACH, Fla. — The Pap Corps Champions for Cancer Research will celebrate its 70th anniversary with a beautiful luncheon event at the Polo Club in Boca Raton on Tuesday, November 15, 2022. During the past seven decades, the nonprofit has grown from a small group of women supporting the pioneering work of Dr. George…
-
Tens of Thousands of Researchers Celebrated During 13th National Postdoc Appreciation Week
ROCKVILLE, Md. — The National Postdoctoral Association (NPA) today kicked off the 13th annual National Postdoc Appreciation Week (NPAW), taking place today through Friday. NPAW is the nation’s largest celebration of postdoctoral scholars who serve at more than 300 institutions, acknowledging the significant contributions “postdocs” make to research, innovation and scientific discovery.
-
Proteios Technology, Inc. Awarded $1.6 Million NIH SBIR Grant to Commercialize its Multivariate Cell Isolation Technology
SEATTLE, Wash. — Proteios Technology, Inc. is pleased to announce it’s received a $1.6 million SBIR Phase II grant from the National Institutes of Health (NIH) to commercialize its multivariate (parallel) cell isolation technology. Grant funds will be used to extend Proteios’ cell isolation kits to include up to 20 of the most common cell…
-
Oral Vaccine Boosts COVID Immunity: study conducted on nonhuman primates is published in the journal Vaccine
ROCHESTER, Minn. — Vyriad, Inc., a clinical-stage biotechnology company developing oncolytic virus therapies to treat a wide range of cancers, today announced results confirming the activity of an oral vaccine formulation for boosting immunity against SARS-CoV-2. The full study conducted on nonhuman primates is published in the journal Vaccine.
-
Myrio Therapeutics and Pure MHC, LLC Announce Research Collaboration to Develop Novel, Targeted Antibody-Based Cancer Therapies
OKLAHOMA CITY, Okla. — Pure MHC, LLC and Myrio Therapeutics Pty Ltd (Myrio) today announced a collaboration to develop new antibody-based oncology therapeutics. The companies will combine Pure MHC’s proprietary offering of MHC peptide targets for oncology with Myrio’s revolutionary Retained Display(tm) (ReD) antibody discovery process to initially create up to three novel therapies based…